Hemostasis News and Research

RSS

Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most times this includes the changing of blood from a fluid to a solid state. Intact blood vessels are central to moderating blood's tendency to clot.

Research into structure of anticoagulant protein may open new avenues for treatment of thrombosis

A collaboration between researchers from Brazil and the United States may open new avenues for the treatment of thrombosis, the leading cause of death among cancer patients.

27 May 2019

HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments.

From HORIBA Medical 25 Mar 2019

PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms

PENTAX Medical announces the addition of new dedicated electrosurgical and argon plasma coagulation platforms – the ENDO ARC and ENDO PLUS – to its therapeutic accessories range.

From PENTAX Medical Company 21 Feb 2019

Drug that reverses blood thinning effects stops acute life-threatening bleeding

A drug that reverses the blood thinning effects of factor Xa inhibitors effectively stopped acute life-threatening bleeding in patients taking a factor Xa inhibitor blood thinner drug, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

New standard of care aims to prevent deaths caused by largely preventable blood clots

A new nationally agreed standard of care released today (Thursday) aims to reduce the tens of thousands of Australian lives put at risk each year by largely preventable blood clots, which kill four times more people than road accidents.

12 Oct 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Researchers develop new model for predicting cancer-associated venous thrombosis

In collaboration with international partners, a study group from the Medical University of Vienna has developed a new model for predicting cancer-associated venous thrombosis/pulmonary embolism.

11 Jul 2018

Studies show link between innovation and reduced surgery complications

Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs

13 Jun 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

Powered stapler use linked to reduced rates of bleeding complications in VATS lobectomy patients

Bleeding complications dropped by nearly half when surgeons used a powered stapler as opposed to a manual device in what researchers say is the first real-world assessment of the two technologies in video-assisted thoracoscopic surgery for lung cancer.

4 May 2018

Researchers fabricate injectable bandage to promote wound healing

A penetrating injury from shrapnel is a serious obstacle in overcoming battlefield wounds that can ultimately lead to death.Given the high mortality rates due to hemorrhaging, there is an unmet need to quickly self-administer materials that prevent fatality due to excessive blood loss.

3 Apr 2018

Researchers find way to effectively stop internal bleeding using magnetically-driven nanoparticles

Scientists from ITMO University have found a way to effectively stop internal bleeding by magnetically-driven nanoparticles containing thrombin.

5 Mar 2018

Researchers identify new anti-inflammatory drug target

A new study suggests that parmodulins may provide anti-inflammatory and anti-thrombotic protection to endothelial cells, without interfering with clotting.

16 Jan 2018

Groundbreaking gene therapy trial brings cure for hemophilia closer

A 'cure' for hemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.

14 Dec 2017

New, more easily administered therapies offer benefits for bleeding and clotting disorders

In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report remarkable benefits from new, more easily administered therapies for bleeding and clotting disorders.

11 Dec 2017

Hemostasis News and Research

Research into structure of anticoagulant protein may open new avenues for treatment of thrombosis

HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms

Drug that reverses blood thinning effects stops acute life-threatening bleeding

New standard of care aims to prevent deaths caused by largely preventable blood clots

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Researchers develop new model for predicting cancer-associated venous thrombosis

Studies show link between innovation and reduced surgery complications

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

Powered stapler use linked to reduced rates of bleeding complications in VATS lobectomy patients

Researchers fabricate injectable bandage to promote wound healing

Researchers find way to effectively stop internal bleeding using magnetically-driven nanoparticles

Researchers identify new anti-inflammatory drug target

Groundbreaking gene therapy trial brings cure for hemophilia closer

New, more easily administered therapies offer benefits for bleeding and clotting disorders

Study finds low public awareness of atrial fibrillation

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery

Novel therapy decreases incidence of bleeding by 87% in hemophilia A patients with inhibitors

Stago Group completes acquisition of HemoSonics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News